DORCHESTER WEALTH MANAGEMENT Co Sells 167 Shares of The Procter & Gamble Company (NYSE:PG)

DORCHESTER WEALTH MANAGEMENT Co decreased its position in The Procter & Gamble Company (NYSE:PGFree Report) by 2.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,888 shares of the company’s stock after selling 167 shares during the period. DORCHESTER WEALTH MANAGEMENT Co’s holdings in Procter & Gamble were worth $1,193,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble in the second quarter valued at approximately $29,000. Ruedi Wealth Management Inc. grew its holdings in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the period. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at $34,000. Finally, Quest Partners LLC bought a new position in shares of Procter & Gamble in the 2nd quarter worth $36,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Down 0.1 %

Shares of NYSE PG traded down $0.12 during midday trading on Thursday, reaching $169.46. The company’s stock had a trading volume of 810,048 shares, compared to its average volume of 6,653,573. The stock has a 50 day simple moving average of $171.88 and a 200-day simple moving average of $167.45. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $399.95 billion, a price-to-earnings ratio of 27.71, a PEG ratio of 3.72 and a beta of 0.41. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period in the previous year, the business earned $1.83 EPS. The company’s revenue was down .6% compared to the same quarter last year. Equities research analysts predict that The Procter & Gamble Company will post 6.98 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is 65.69%.

Insider Transactions at Procter & Gamble

In related news, insider Susan Street Whaley sold 450 shares of the business’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now directly owns 13,072 shares in the company, valued at approximately $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Susan Street Whaley sold 450 shares of Procter & Gamble stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the completion of the transaction, the insider now owns 13,072 shares in the company, valued at approximately $2,212,043.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Shailesh Jejurikar sold 10,623 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total value of $1,797,624.06. Following the completion of the sale, the chief operating officer now owns 23,890 shares in the company, valued at $4,042,665.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 385,186 shares of company stock worth $65,479,358 in the last 90 days. Corporate insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on PG shares. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a report on Monday, September 30th. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research note on Thursday, August 29th. Evercore ISI lifted their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday. Morgan Stanley upped their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday. Finally, JPMorgan Chase & Co. lifted their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Nine equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $177.00.

Read Our Latest Research Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.